Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Genitourinary 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatitis 1Pancreatic Neoplasms 1Helicobacter Infections 1Gastritis, Atrophic 1Duodenal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pantoprazole × Gastrointestinal × Clear all
NCT05251233 2025-05-06

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Washington University School of Medicine

Phase 2 Terminated
56 enrolled 11 charts
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis

NCT06856447 2025-03-04

The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Tanta University

Phase 1 Recruiting
22 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02449941 2016-12-06

Helicobacter Pylori and Proton Pump Inhibitor

Asan Medical Center

Completed
30 enrolled
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms, Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡